Differences in erythrocyte phospholipid membrane long-chain polyunsaturated fatty acids and the prevalence of fatty acid desaturase genotype among African Americans and European Americans

Prostaglandins Leukot Essent Fatty Acids. 2021 Jan:164:102216. doi: 10.1016/j.plefa.2020.102216. Epub 2020 Nov 19.

Abstract

Numerous studies have reported an association between genetic variants in fatty acid desaturases (FADS1 and FADS2) and plasma or erythrocyte long chain polyunsaturated fatty acid (PUFA) levels. Increased levels of n-6 PUFAs have been associated with inflammation and several chronic diseases, including diabetes and cancer. We hypothesized that genetic variants of FADS that more efficiently convert precursor n-6 PUFA to arachidonic acid (AA) may explain the higher burden of chronic diseases observed in African Americans. To test this hypothesis, we measured the level of n-6 and n-3 PUFAs in erythrocyte membrane phospholipids and genotyped the rs174537 FADS variants associated with higher AA conversion among African American and European American populations. We included data from 1,733 individuals who participated in the Tennessee Colorectal Polyp Study, a large colonoscopy-based case-control study. Erythrocyte membrane PUFA percentages were measured using gas chromatography. Generalized linear models were used to estimate association of race and genotype on erythrocyte phospholipid membrane PUFA levels while controlling for self-reported dietary intake. We found that African Americans have higher levels of AA and a higher prevalence of GG allele compared to whites, 81% vs 43%, respectively. Homozygous GG genotype was negatively associated with precursor PUFAs (linoleic [LA], di-homo-γ-linolenic [DGLA]), positively associated with both product PUFA (AA, docosahexaenoic acid [DHA]), product to precursor ratio (AA to DGLA), an indirect measure of FADs efficiency and increased urinary isoprostane F2 (F2-IsoP) and isoprostane F3 (F3-IsoP), markers of oxidative stress. Increased consumption of n-6 PUFA and LA resulting in increased AA and subsequent inflammation may be fueling increased prevalence of chronic diseases especially in African descent.

Keywords: Arachidonic acid (AA); Di-homo-γ-linoleic acid (DGLA); Docosahexaenoic acid (DHA); Docosapentaenoic acid (DPA); Eicosapentaenoic acid (EPA); Fatty acid desaturase (FADS); Linoleic acid (LA); Polyunsaturated fatty acid (PUFA); Urinary prostaglandin E(2) metabolite (PGEM); α-linoleic acid (ALA).

Publication types

  • Clinical Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Black or African American / genetics*
  • Delta-5 Fatty Acid Desaturase
  • Erythrocyte Membrane* / genetics
  • Erythrocyte Membrane* / metabolism
  • Fatty Acid Desaturases* / genetics
  • Fatty Acid Desaturases* / metabolism
  • Fatty Acids, Unsaturated* / genetics
  • Fatty Acids, Unsaturated* / metabolism
  • Female
  • Humans
  • Male
  • Middle Aged
  • Phospholipids* / genetics
  • Phospholipids* / metabolism
  • Polymorphism, Single Nucleotide*
  • White People / genetics*

Substances

  • Delta-5 Fatty Acid Desaturase
  • Fatty Acids, Unsaturated
  • Phospholipids
  • Fatty Acid Desaturases
  • FADS1 protein, human
  • FADS2 protein, human